Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, ph... by Ledermann, Jonathan A, Prof, Oza, Amit M, MD, Lorusso, Domenica, MD, Aghajanian, Carol, MD, Oaknin, Ana, MD, Dean, Andrew, MD, Colombo, Nicoletta, Prof, Weberpals, Johanne I, MD, Clamp, Andrew R, PhD, Scambia, Giovanni, MD, Leary, Alexandra, MD, Holloway, Robert W, MD, Gancedo, Margarita Amenedo, MD, Fong, Peter C, FRACP, Goh, Jeffrey C, FRACP, O'Malley, David M, MD, Armstrong, Deborah K, MD, Banerjee, Susana, PhD, García-Donas, Jesus, MD, Swisher, Elizabeth M, Prof, Cameron, Terri, MSc, Maloney, Lara, BA, Goble, Sandra, MS, Coleman, Robert L, MD

Get full text

LIO-1: Initial phase 2 experience of lucitanib + nivolumab in patients with metastatic or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO) (034) by Oaknin, Ana, MD, PhD, Backes, Floor, MD, Nieuwenhuysen, Els Van, MD, PhD, Eskander, Ramez, MD, González-Martín, Antonio, MD, PhD, Makker, Vicky, MD, Marth, Christian, MD, Patel, Manish, MD, Penson, Richard, MD, Redondo, Andrés, MD, PhD, Pérez, Maria Jesús Rubio, MD, PhD, Hamilton, Erika, MD, Concin, Nicole, MD, McNees, Alexander, BS, MPH, Wride, Kenton, MS, Lepley, Denise, PhD, Dusek, Rachel, PhD, Cameron, Terri, MSc, Pignata, Sandro, MD

Get full text